Literature DB >> 26084352

Intensity modulated proton therapy.

H M Kooy1, C Grassberger1.   

Abstract

Intensity modulated proton therapy (IMPT) implies the electromagnetic spatial control of well-circumscribed "pencil beams" of protons of variable energy and intensity. Proton pencil beams take advantage of the charged-particle Bragg peak-the characteristic peak of dose at the end of range-combined with the modulation of pencil beam variables to create target-local modulations in dose that achieves the dose objectives. IMPT improves on X-ray intensity modulated beams (intensity modulated radiotherapy or volumetric modulated arc therapy) with dose modulation along the beam axis as well as lateral, in-field, dose modulation. The clinical practice of IMPT further improves the healthy tissue vs target dose differential in comparison with X-rays and thus allows increased target dose with dose reduction elsewhere. In addition, heavy-charged-particle beams allow for the modulation of biological effects, which is of active interest in combination with dose "painting" within a target. The clinical utilization of IMPT is actively pursued but technical, physical and clinical questions remain. Technical questions pertain to control processes for manipulating pencil beams from the creation of the proton beam to delivery within the patient within the accuracy requirement. Physical questions pertain to the interplay between the proton penetration and variations between planned and actual patient anatomical representation and the intrinsic uncertainty in tissue stopping powers (the measure of energy loss per unit distance). Clinical questions remain concerning the impact and management of the technical and physical questions within the context of the daily treatment delivery, the clinical benefit of IMPT and the biological response differential compared with X-rays against which clinical benefit will be judged. It is expected that IMPT will replace other modes of proton field delivery. Proton radiotherapy, since its first practice 50 years ago, always required the highest level of accuracy and pioneered volumetric treatment planning and imaging at a level of quality now standard in X-ray therapy. IMPT requires not only the highest precision tools but also the highest level of system integration of the services required to deliver high-precision radiotherapy.

Entities:  

Mesh:

Year:  2015        PMID: 26084352      PMCID: PMC4628542          DOI: 10.1259/bjr.20150195

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  61 in total

1.  Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning.

Authors:  Jan Unkelbach; Thomas Bortfeld; Benjamin C Martin; Martin Soukup
Journal:  Med Phys       Date:  2009-01       Impact factor: 4.071

2.  Increasing maximum tumor dose to manage range uncertainties in IMPT treatment planning.

Authors:  Steven Petit; Joao Seco; Hanne Kooy
Journal:  Phys Med Biol       Date:  2013-09-27       Impact factor: 3.609

3.  Does kV-MV dual-energy computed tomography have an advantage in determining proton stopping power ratios in patients?

Authors:  M Yang; G Virshup; J Clayton; X R Zhu; R Mohan; L Dong
Journal:  Phys Med Biol       Date:  2011-06-30       Impact factor: 3.609

Review 4.  Motion in radiotherapy: particle therapy.

Authors:  C Bert; M Durante
Journal:  Phys Med Biol       Date:  2011-07-20       Impact factor: 3.609

5.  Cone beam computerized tomography: the effect of calibration of the Hounsfield unit number to electron density on dose calculation accuracy for adaptive radiation therapy.

Authors:  Joan Hatton; Boyd McCurdy; Peter B Greer
Journal:  Phys Med Biol       Date:  2009-07-10       Impact factor: 3.609

6.  Joint CT/CBCT deformable registration and CBCT enhancement for cancer radiotherapy.

Authors:  Yifei Lou; Tianye Niu; Xun Jia; Patricio A Vela; Lei Zhu; Allen R Tannenbaum
Journal:  Med Image Anal       Date:  2013-02-04       Impact factor: 8.545

Review 7.  Motion in radiotherapy: photon therapy.

Authors:  Stine S Korreman
Journal:  Phys Med Biol       Date:  2012-12-07       Impact factor: 3.609

8.  TOPAS: an innovative proton Monte Carlo platform for research and clinical applications.

Authors:  J Perl; J Shin; J Schumann; B Faddegon; H Paganetti
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

9.  Site-specific range uncertainties caused by dose calculation algorithms for proton therapy.

Authors:  J Schuemann; S Dowdell; C Grassberger; C H Min; H Paganetti
Journal:  Phys Med Biol       Date:  2014-07-03       Impact factor: 3.609

Review 10.  Range uncertainties in proton therapy and the role of Monte Carlo simulations.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2012-05-09       Impact factor: 3.609

View more
  12 in total

1.  A gas scintillator detector for 2D dose profile monitoring in pencil beam scanning and pulsed beam proton radiotherapy treatments.

Authors:  S E Vigdor; A V Klyachko; K A Solberg; M Pankuch
Journal:  Phys Med Biol       Date:  2017-04-12       Impact factor: 3.609

Review 2.  Empowering Intensity Modulated Proton Therapy Through Physics and Technology: An Overview.

Authors:  Radhe Mohan; Indra J Das; Clifton C Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-10-01       Impact factor: 7.038

3.  Performance characterization of a 3D liquid scintillation detector for discrete spot scanning proton beam systems.

Authors:  Chinmay D Darne; Fahed Alsanea; Daniel G Robertson; Narayan Sahoo; Sam Beddar
Journal:  Phys Med Biol       Date:  2017-06-23       Impact factor: 3.609

Review 4.  Charged-particle therapy in cancer: clinical uses and future perspectives.

Authors:  Marco Durante; Roberto Orecchia; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

5.  Sparsity constrained split feasibility for dose-volume constraints in inverse planning of intensity-modulated photon or proton therapy.

Authors:  Scott Penfold; Rafał Zalas; Margherita Casiraghi; Mark Brooke; Yair Censor; Reinhard Schulte
Journal:  Phys Med Biol       Date:  2017-04-05       Impact factor: 3.609

Review 6.  Preserving the legacy of reirradiation: A narrative review of historical publications.

Authors:  Carsten Nieder; Johannes A Langendijk; Matthias Guckenberger; Anca L Grosu
Journal:  Adv Radiat Oncol       Date:  2017-02-28

Review 7.  New frontiers in proton therapy: applications in cancers.

Authors:  Tai-Ze Yuan; Ze-Jiang Zhan; Chao-Nan Qian
Journal:  Cancer Commun (Lond)       Date:  2019-10-22

8.  Robust contour propagation using deep learning and image registration for online adaptive proton therapy of prostate cancer.

Authors:  Mohamed S Elmahdy; Thyrza Jagt; Roel Th Zinkstok; Yuchuan Qiao; Rahil Shahzad; Hessam Sokooti; Sahar Yousefi; Luca Incrocci; C A M Marijnen; Mischa Hoogeman; Marius Staring
Journal:  Med Phys       Date:  2019-07-12       Impact factor: 4.071

Review 9.  Proton beam therapy: clinical utility and current status in prostate cancer.

Authors:  Kosj Yamoah; Peter As Johnstone
Journal:  Onco Targets Ther       Date:  2016-09-16       Impact factor: 4.147

Review 10.  Current Advances in the Management of Adult Craniopharyngiomas.

Authors:  Montserrat Lara-Velazquez; Yusuf Mehkri; Eric Panther; Jairo Hernandez; Dinesh Rao; Peter Fiester; Raafat Makary; Michael Rutenberg; Daryoush Tavanaiepour; Gazanfar Rahmathulla
Journal:  Curr Oncol       Date:  2022-03-04       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.